SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Djordje Atanackovic, Henrike Reinhard, Sabrina Meyer, Stefanie Spöck, Tobias Grob, Tim Luetkens, Sara Yousef, Yanran Cao, York Hildebrandt, Julia Templin, Katrin Bartels, Nesrine Lajmi, Heribert Stoiber, Nicolaus Kröger, Judith Atz, Diane Seimetz, Jakob R Izbicki, Carsten Bokemeyer, The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting, Human vaccines & immunotherapeutics, 2013, 9, 12, 2533

    CrossRef

  2. 2
    Juergen Hess, Peter Ruf, Horst Lindhofer, Cancer therapy with trifunctional antibodies: linking innate and adaptive immunity, Future Oncology, 2012, 8, 1, 73

    CrossRef

  3. 3
    Petra Schroeder, Carsten Lindemann, Kirsten Dettmar, Jürgen Brieger, Jan Gosepath, Benjamin Pogorzelski, Diane Seimetz, Judith Atz, Trifunctional antibodies induce efficient antitumour activity with immune cells from head and neck squamous cell carcinoma patients after radio-chemotherapy treatment, Clinical and Translational Oncology, 2011, 13, 12, 889

    CrossRef

  4. 4
    Franziska Hirschhaeuser, Stefan Walenta, Wolfgang Mueller-Klieser, Efficacy of catumaxomab in tumor spheroid killing is mediated by its trifunctional mode of action, Cancer Immunology, Immunotherapy, 2010, 59, 11, 1675

    CrossRef

  5. You have free access to this content5
    Barry L. Ziober, Michael G. Mauk, Erica M. Falls, Zongyuan Chen, Amy F. Ziober, Haim H. Bau, Lab-on-a-chip for oral cancer screening and diagnosis, Head & Neck, 2008, 30, 1
  6. 6
    Herbert Riechelmann, Markus Wiesneth, Peter Schauwecker, Peter Reinhardt, Silke Gronau, Anita Schmitt, Carsten Schroen, Judith Atz, Michael Schmitt, Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial, Cancer Immunology, Immunotherapy, 2007, 56, 9, 1397

    CrossRef